Hydroxytertatolol
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
|
|
Synonyms | 4-Hydroxytertatolol |
PubChem (CID) | 163871 |
ChemSpider | 143721 |
Chemical and physical data | |
Formula | C16H25NO3S |
Molar mass | 311.44 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Hydroxytertatolol is a beta blocker.[1][2] It is a derivative of tertatolol.
References[edit]
- ^ T. Lave; C. Efthymiopoulos; D. Christmann; J. C. Koffel; L. Jung (1995). "Determination of 4-Hydroxytertatolol Stereoisomers in Rat and Human Urine by High-Performance Liquid Chromatography". Journal of Liquid Chromatography. 18 (14): 2801–2812. doi:10.1080/10826079508009325.
- ^ Bastian G, Urien S, Brée F, Jolliet P, Rocher I, Crambes O, Tillement JP (1992). "Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins". Eur J Drug Metab Pharmacokinet. 17 (3): 233–236. doi:10.1007/bf03190151. PMID 1362702.
![]() |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |